Treating Platinum-resistant Ovarian Cancer and Advanced Cervical Cancer with AVASTIN
On January 19th, 2015
Date: Tuesday, January 20, 2015
Arrival Time: 6:00 PM Central Time
Presentation Time: 6:30 PM Central Time
Location: Broadway 1 0 Bar & Chophouse
1101 North Broadway Avenue, Suite 101
Oklahoma City, OK 73103
Audience: This oncology program has been developed for physician peer-to-peer discussion and participation.
Program Overview: The goal of this program is to describe the indication and proposed mechanism of action for Avastin® (bevacizumab) and review efficacy and safety data of platinum-resistant ovarian cancer and advanced cervical cancer.
Presented by: John Farley, M D
St. Joseph’s Hospital and Medical Center
Phoenix, AZ
Hosted by: Lindsey Baker, Genentech
To RSVP: Visit http://www.medforcereg.net/SGEN1904 or contact Lindsey Baker at 405-819-9312 or Baker.Lindsey@Gene.Com
Event Code: MF01904
* Click on article title for more information.
Date: Tuesday, January 20, 2015
Arrival Time: 6:00 PM Central Time
Presentation Time: 6:30 PM Central Time
Location: Broadway 1 0 Bar & Chophouse
1101 North Broadway Avenue, Suite 101
Oklahoma City, OK 73103
Audience: This oncology program has been developed for physician peer-to-peer discussion and participation.
Program Overview: The goal of this program is to describe the indication and proposed mechanism of action for Avastin® (bevacizumab) and review efficacy and safety data of platinum-resistant ovarian cancer and advanced cervical cancer.
Presented by: John Farley, M D
St. Joseph’s Hospital and Medical Center
Phoenix, AZ
Hosted by: Lindsey Baker, Genentech
To RSVP: Visit http://www.medforcereg.net/SGEN1904 or contact Lindsey Baker at 405-819-9312 or Baker.Lindsey@Gene.Com
Event Code: MF01904
* Click on article title for more information.
No comments have been posted yet.